Based on findings from a nationwide study recently published in the Annals of Internal Medicine, it was found out of nearly 1.2 million children that early childhood exposure to aluminum in vaccines is not linked to the increased the risk of autoimmune, allergic or neurodevelopmental disorders.

Aluminum-based adjuvants are widely used in non-live vaccines to boost the immune response by binding vaccine antigens. Common early childhood vaccines containing aluminum include those for diphtheria, tetanus, pertussis, Haemophilus influenzae type b (Hib), pneumococcal conjugate vaccine (PCV) and hepatitis A and B. While these vaccines have been administered safely worldwide for decades, concerns persist about potential harms.

Animal studies have also suggested that aluminum exposure could h

See Full Page